» Articles » PMID: 38155968

Comprehensive Analysis of Mitophagy-related Genes in NSCLC Diagnosis and Immune Scenery: Based on Bulk and Single-cell RNA Sequencing Data

Overview
Journal Front Immunol
Date 2023 Dec 29
PMID 38155968
Authors
Affiliations
Soon will be listed here.
Abstract

Lung cancer is the main cause of cancer-related deaths, and non-small cell lung cancer (NSCLC) is the most common type. Understanding the potential mechanisms, prognosis, and treatment aspects of NSCLC is essential. This study systematically analyzed the correlation between mitophagy and NSCLC. Six mitophagy-related feature genes (, , , , , and ) were selected through machine learning and used to construct a diagnostic model for NSCLC. These feature genes are closely associated with the occurrence and development of NSCLC. Additionally, NSCLC was divided into two subtypes using unsupervised consensus clustering, and their differences in clinical characteristics, immune infiltration, and immunotherapy were systematically analyzed. Furthermore, the interaction between mitophagy-related genes (MRGs) and immune cells was analyzed using single-cell sequencing data. The findings of this study will contribute to the development of potential diagnostic biomarkers for NSCLC and the advancement of personalized treatment strategies.

Citing Articles

Identification of potential diagnostic targets and therapeutic strategies for anoikis-related biomarkers in lung squamous cell carcinoma using machine learning and computational virtual screening.

Zhang X, Zou J, Ning J, Zhao Y, Qu R, Zhang Y Front Pharmacol. 2025; 16:1500968.

PMID: 40028162 PMC: 11868076. DOI: 10.3389/fphar.2025.1500968.


An Integrated Approach Utilizing Single-Cell and Bulk RNA-Sequencing for the Identification of a Mitophagy-Associated Genes Signature: Implications for Prognostication and Therapeutic Stratification in Prostate Cancer.

Zhang Y, Ding L, Zhang Z, Shen L, Guo Y, Zhang W Biomedicines. 2025; 13(2).

PMID: 40002724 PMC: 11853322. DOI: 10.3390/biomedicines13020311.


Comprehensive multi-omics integration uncovers mitochondrial gene signatures for prognosis and personalized therapy in lung adenocarcinoma.

Zhang W, Zhao L, Zheng T, Fan L, Wang K, Li G J Transl Med. 2024; 22(1):952.

PMID: 39434164 PMC: 11492473. DOI: 10.1186/s12967-024-05754-y.


Evaluation of Mitochondrial Phagy (Mitophagy) in Human Non-small Adenocarcinoma Tumor Cells.

Alizadeh J, da Silva Rosa S, Cordani M, Ghavami S Methods Mol Biol. 2024; 2879:261-273.

PMID: 38607594 DOI: 10.1007/7651_2024_532.

References
1.
Chang G, Zhang W, Ma Y, Wen Q . PINK1 Expression Is Associated with Poor Prognosis in Lung Adenocarcinoma. Tohoku J Exp Med. 2018; 245(2):115-121. DOI: 10.1620/tjem.245.115. View

2.
Liu L, Zuo Z, Lu S, Wang L, Liu A, Liu X . Silencing of PINK1 represses cell growth, migration and induces apoptosis of lung cancer cells. Biomed Pharmacother. 2018; 106:333-341. DOI: 10.1016/j.biopha.2018.06.128. View

3.
Wilkerson M, Hayes D . ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010; 26(12):1572-3. PMC: 2881355. DOI: 10.1093/bioinformatics/btq170. View

4.
Takanami I, Takeuchi K, Naruke M . Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma. Cancer. 2000; 88(12):2686-92. View

5.
Zhang X, Lan Y, Xu J, Quan F, Zhao E, Deng C . CellMarker: a manually curated resource of cell markers in human and mouse. Nucleic Acids Res. 2018; 47(D1):D721-D728. PMC: 6323899. DOI: 10.1093/nar/gky900. View